Skip to main content
Clinical Trials/CTRI/2021/01/030781
CTRI/2021/01/030781
Completed
Phase 2

A clinical trial to evaluate the effect of specialized treatment protocol using Takra in the management of Grahani Dosha with special reference to Irritable bowel syndrome - STPTGDIBS

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Ayurveda
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients irrespective of sex, religion, occupation will be selected for study.
  • 2\. Patients having pratyatma lakshana of Grahani Dosha especially – Atisrushtam or Ativibadhham or Atidravam malapravritti (altered bowel
  • habits), Trushna, Arochaaka, Vairasya, Praseka, Tamaka, Shoona pada,
  • Shoona kara, Asthi\-parva ruja, Chhardi, Jwara, Louha\-ama\-gandhi
  • tiktamlodgara.
  • 3\. The patients who are diagnosed with IBS according to standard ROME IV criteria.
  • 4\. Previously diagnosed case of IBS.
  • 5\. Able and willing to give written informed consent.

Exclusion Criteria

  • Mixed infection with parasites such as round worms, hook worms etc.
  • 1\. Ulcerative colitis, Crohn’s disease, gastric ulcerations and other inflammatory
  • bowel conditions.
  • 2\. Infectious disorders like Intestinal tuberculosis etc.
  • 3\. Patients with evidence of malignancy.
  • 4\. Patents with diabetes mellitus (FBS \>126 mg/dl, PP \>200 mg/dl), poorly
  • controlled hypertension, Thyroid disorders and any other autoimmune disorders.
  • 5\. Amoebic dysentery, acute diarrhoea.
  • 6\. Lactose intolerance patients.
  • 7\. Abuse of drug or alcohol.

Outcomes

Primary Outcomes

Not specified

Similar Trials